These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 14004979)
21. Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor. Caprio M; Zennaro MC; Fève B; Mammi C; Fabbri A; Rosano G Climacteric; 2008 Jun; 11(3):258-64. PubMed ID: 18568791 [TBL] [Abstract][Full Text] [Related]
22. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension. Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132 [TBL] [Abstract][Full Text] [Related]
23. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy]. Fronczyk A; Majkowska L Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038 [TBL] [Abstract][Full Text] [Related]
24. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Dieterich HA; Wendt C; Saborowski F Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159 [TBL] [Abstract][Full Text] [Related]
25. Aldosterone inhibition reduces the risk of sudden cardiac death in patients with heart failure. Anand K; Mooss AN; Mohiuddin SM J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):15-9. PubMed ID: 17083069 [TBL] [Abstract][Full Text] [Related]
26. Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction. Greenberg B; Zannad F; Pitt B Am J Cardiol; 2006 May; 97(10A):34F-40F. PubMed ID: 16698333 [TBL] [Abstract][Full Text] [Related]
27. Effect of spironolactone on C-reactive protein levels in patients with heart disease. Godfrey V; Farquharson CA; Macdonald JE; Yee KM; Struthers AD Int J Cardiol; 2007 Apr; 117(2):282-4. PubMed ID: 16899309 [TBL] [Abstract][Full Text] [Related]
28. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
29. [Initial results in the spirolactone treatment of 2 cases of the edematous syndrome with secondary aldosteronism]. DULAC JF; OUGIER J; DOURY P; BEN-ZENOU A; WEIL B Bull Mens Soc Med Mil Fr; 1960 Dec; 54():332-5. PubMed ID: 13724900 [No Abstract] [Full Text] [Related]
30. [Diuretic properties of a spirolactone]. SCHWARTZ J; BLOCH R Strasb Med; 1961 Feb; 12():103-13. PubMed ID: 13749099 [No Abstract] [Full Text] [Related]
31. The 45-year story of the development of an anti-aldosterone more specific than spironolactone. Ménard J Mol Cell Endocrinol; 2004 Mar; 217(1-2):45-52. PubMed ID: 15134800 [TBL] [Abstract][Full Text] [Related]
32. [Clinical and biological efficacy of a spirolactone in the treatment of various water-salt retentions]. WAREMBOURG H; LINQUETTE M; LEKIEFFRE J; FOSSATI P Lille Med; 1961; 6():668-71. PubMed ID: 14004979 [No Abstract] [Full Text] [Related]
33. Interactions of high salt intake and the response of the cardiovascular system to aldosterone. Conlin PR Cardiol Rev; 2005; 13(3):118-24. PubMed ID: 15831143 [TBL] [Abstract][Full Text] [Related]